165 related articles for article (PubMed ID: 24154604)
1. Pulmonary arterial hypertension: challenges in translational research and a vision for change.
Sutendra G; Michelakis ED
Sci Transl Med; 2013 Oct; 5(208):208sr5. PubMed ID: 24154604
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies and future directions in pulmonary arterial hypertension.
Gurtu V; Michelakis ED
Can J Cardiol; 2015 Apr; 31(4):489-501. PubMed ID: 25840098
[TBL] [Abstract][Full Text] [Related]
3. Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.
Provencher S; Archer SL; Ramirez FD; Hibbert B; Paulin R; Boucherat O; Lacasse Y; Bonnet S
Circ Res; 2018 Mar; 122(7):1021-1032. PubMed ID: 29599278
[TBL] [Abstract][Full Text] [Related]
4. The ethics of randomized clinical trials in pulmonary arterial hypertension.
Halpern SD; Doyle R; Kawut SM
Proc Am Thorac Soc; 2008 Jul; 5(5):631-5. PubMed ID: 18625756
[TBL] [Abstract][Full Text] [Related]
5. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.
Sakao S; Tatsumi K
Int J Cardiol; 2011 Feb; 147(1):4-12. PubMed ID: 20692712
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
Waxman AB; Zamanian RT
Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
[TBL] [Abstract][Full Text] [Related]
7. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
8. Inhalation therapy to treat pulmonary arterial hypertension.
Baradia D; Khatri N; Trehan S; Misra A
Pharm Pat Anal; 2012 Nov; 1(5):577-88. PubMed ID: 24236926
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for pulmonary hypertension: prospects and challenges.
Reynolds PN
Expert Opin Biol Ther; 2011 Feb; 11(2):133-43. PubMed ID: 21219232
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
11. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
Jurasz P; Courtman D; Babaie S; Stewart DJ
Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cell-based therapy for pulmonary arterial hypertension.
Yang JX; Pan YY; Zhao YY; Wang XX
Cell Transplant; 2013; 22(8):1325-36. PubMed ID: 23295102
[TBL] [Abstract][Full Text] [Related]
13. Current therapies for pulmonary arterial hypertension.
Takaoka S; Faul JL; Doyle R
Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
15. Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries.
Benza RL; Gomberg-Maitland M; Frost AE; Frantz RP; Humbert M; McGoon MD
Thromb Haemost; 2012 Dec; 108(6):1049-60. PubMed ID: 22955290
[TBL] [Abstract][Full Text] [Related]
16. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of pulmonary hypertension.
Yildiz P
Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension: modern diagnostics and therapy--Part 1].
Betkier-Lipińska K; Ryczek R; Kwasiborski P; Cwetsch A
Pol Merkur Lekarski; 2013 Jun; 34(204):355-9. PubMed ID: 23882936
[TBL] [Abstract][Full Text] [Related]
19. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
